Thierry B. Thaure Net Worth

The estimated Net Worth of Thierry B. Thaure is at least $171 Mille dollars as of 12 May 2017. Thierry Thaure owns over 10,000 units of Pulse Biosciences Inc stock worth over $171,400 and over the last 8 years Thierry sold PLSE stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Thierry Thaure PLSE stock SEC Form 4 insiders trading

Thierry has made over 2 trades of the Pulse Biosciences Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Thierry exercised 10,000 units of PLSE stock worth $26,700 on 12 May 2017.

The largest trade Thierry's ever made was exercising 15,000 units of Pulse Biosciences Inc stock on 8 May 2017 worth over $40,050. On average, Thierry trades about 8,333 units every 1 days since 2017. As of 12 May 2017 Thierry still owns at least 10,000 units of Pulse Biosciences Inc stock.

You can see the complete history of Thierry Thaure stock trades at the bottom of the page.

What's Thierry Thaure's mailing address?

Thierry's mailing address filed with the SEC is 849 MITTEN ROAD, SUITE 104, , BURLINGAME, CA, 94010.

Insiders trading at Pulse Biosciences Inc

Over the last 8 years, insiders at Pulse Biosciences Inc have traded over $0 worth of Pulse Biosciences Inc stock and bought 18,070,761 units worth $194,618,110 . The most active insiders traders include Robert W Duggan, Mahkam Zanganeh e Manmeet Singh Soni. On average, Pulse Biosciences Inc executives and independent directors trade stock every 52 days with the average trade being worth of $6,179,107. The most recent stock trade was executed by Burke Thomas Barrett on 20 May 2024, trading 10,000 units of PLSE stock currently worth $85,600.

What does Pulse Biosciences Inc do?

pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and

Complete history of Thierry Thaure stock trades at Pulse Biosciences Inc

Pulse Biosciences Inc executives and stock owners

Pulse Biosciences Inc executives and other stock owners filed with the SEC include:

• Sandra Gardiner,
  Chief Financial Officer, Executive Vice President - Finance, Treasurer, Secretary
• Darrin Uecker,
  President, Chief Executive Officer, Director
• Darrin R. Uecker,
  Pres, CEO & Director
• Sandra A. Gardiner,
  Exec. VP of Fin. & Admin., CFO, Sec. and Treasurer
• Mitchell Levinson,
  Independent Director
• Edward A. Ebbers,
  Exec. VP & GM of Dermatology
• Edward Ebbers,
  Executive Vice President, General Manager - Dermatology
• Manmeet Soni,
  Independent Director
• Robert Duggan,
  Independent Chairman of the Board
• Kenneth Clark,
  Independent Director
• Mahkam Zanganeh,
  Independent Director
• Mitchell E. Levinson,
  Chief Strategy Officer & Director
• David Danitz,
  Sr. VP of Engineering
• Patty Perla,
  VP of HR
• Dr. Holly Hartman Ph.D., J.D.,
  VP of Bus. Devel. & Corp. Strategy
• Dr. Richard Nuccitelli Ph.D.,
  Chief Science Officer
• Thierry B. Thaure,
  Director
• Robert J. Greenberg,
  Director
• Robert Levande,
  Director
• Brian B Dow,
  CFO & SVP Admin. and Finance
• Thomas J M D Fogarty,
  Director
• Burke Thomas Barrett,
  President and CEO
• Ed Ebbers,
  EVP & GM, Dermatology
• Den Broek Richard Van,
  Director
• Laureen Debuono,
  Director
• Shelley D Spray,
  Director
• Kevin Patrick Danahy,
  Chief Commercial Officer
• Paul A Laviolette,
  Director